Shiva Shahrara Selected Research

Shiva Shahrara Research Topics

Disease

32	Rheumatoid Arthritis 07/2022 - 01/2002
17	Arthritis (Polyarthritis) 01/2022 - 12/2003
15	Inflammation (Inflammations) 07/2022 - 12/2003
9	Experimental Arthritis 01/2022 - 04/2010
7	Osteoarthritis 01/2021 - 01/2002
5	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 10/2011
3	Hypoxia (Hypoxemia) 01/2022 - 10/2015
2	COVID-19 01/2021 - 01/2021
2	Psoriatic Arthritis 01/2021 - 04/2011
2	Obesity 08/2018 - 01/2017
2	Prostatitis 10/2010 - 05/2008
2	Pelvic Pain 10/2010 - 05/2008
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Synovitis 01/2021
1	Necrosis 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Infections 01/2014
1	Neoplasms (Cancer) 01/2014
1	Spinal Diseases (Disease, Spinal) 01/2014
1	Chronic Disease (Chronic Diseases) 05/2013
1	Multiple Sclerosis 10/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2011
1	Hypertrophy 08/2011
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2011
1	Fibrosis (Cirrhosis) 09/2009
1	Wounds and Injuries (Trauma) 09/2009
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2008
1	Pain (Aches) 05/2008
1	Pathologic Neovascularization 08/2007

Drug/Important Bio-Agent (IBA)

10	ChemokinesIBA 04/2020 - 10/2006
10	CytokinesIBA 10/2015 - 06/2005
8	Interleukin-17 (Interleukin 17)IBA 10/2020 - 03/2009
5	LigandsIBA 01/2021 - 01/2002
4	Interleukin-7 (Interleukin 7)IBA 07/2022 - 10/2011
4	EnzymesIBA 01/2014 - 06/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
3	Interleukin-27 (Interleukin 27)IBA 04/2013 - 01/2008
3	ImmunosorbentsIBA 04/2011 - 06/2005
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2010 - 03/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2014
2	Interleukin-12 (IL 12)IBA 01/2021 - 04/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2017 - 01/2017
2	Toll-Like Receptor 7IBA 01/2016 - 03/2013
2	InterleukinsIBA 10/2015 - 01/2008
2	Immunoglobulin G (IgG)IBA 05/2013 - 12/2011
2	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 05/2013 - 10/2011
2	Chemokine CCL5IBA 03/2008 - 10/2006
2	Messenger RNA (mRNA)IBA 03/2006 - 12/2003
2	CC ChemokinesIBA 06/2005 - 12/2003
2	Chemokine ReceptorsIBA 06/2005 - 12/2003
1	Estrogens (Estrogen)FDA Link 01/2022
1	PPAR gammaIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Pyruvic Acid (Pyruvate)IBA 11/2021
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 11/2021
1	Syndecan-1 (Syndecan 1)IBA 11/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	MonokinesIBA 01/2021
1	LymphokinesIBA 01/2021
1	tofacitinibIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	ArginaseIBA 01/2020
1	Interleukin-11 (Interleukin 11)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Toll-Like Receptor 4IBA 10/2015
1	Matrix Metalloproteinases (MMPs)IBA 10/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	tocilizumab (atlizumab)FDA Link 01/2014
1	Toll-Like Receptor 5IBA 08/2013
1	FlagellinIBA 08/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	Neutralizing AntibodiesIBA 12/2011
1	C-Reactive ProteinIBA 10/2011
1	Chemotactic FactorsIBA 10/2010
1	Interleukin-18 (Interleukin 18)IBA 01/2010
1	ZymosanIBA 01/2010
1	CollagenIBA 09/2009
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2009
1	Transcription Factors (Transcription Factor)IBA 09/2009
1	Biomarkers (Surrogate Marker)IBA 05/2008
1	CCR5 Receptors (CCR5 Receptor)IBA 03/2008
1	Interleukin-23 (Interleukin 23)IBA 01/2008
1	InterferonsIBA 01/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2007
7	Ligation 01/2022 - 03/2013
1	Biological Therapy 01/2021
1	Continuity of Patient Care 01/2021
1	Organ Transplantation 01/2014